Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 197 results for "Zegerid"

HC Stocks Newsbeat: Perrigo Company plc Ordinary Shares (NYSE:PRGO), Fate Therapeutics Inc (NASDAQ:FATE)
Share Market Updates

8/5/16 - Perrigo Announces FDA Final Approval And Launch Of Th...

8/5/16 - Perrigo Announces FDA Final Approval And Launch Of The Store Brand Equivalent To Zegerid OTC Capsules By a News Reporter-Staff News Editor at Drug Week Perrigo Company plc (NYSE: PRGO; TASE) announced that the U.S. Food and Drug ... Pharmacy Choice, 1 month ago
Perrigo releases store-brand version of Zegerid OTC Chain Drug Review, 2 months ago
FDA OKs Perrigo's generic Zegerid OTC capsules Seeking Alpha, 2 months ago
[x]  

2 images for "Zegerid"

Drug Store News, 3 days ago
Drug Store News, 2 months ago
WorldNetDaily

Ajanta Pharma - G-Zegerid, a good opportunity for Ajanta: AnandRathi Institutional Research

Posted On: 2016-07-31 09:01:32 Ajanta Pharma - G-Zegerid, a good opportunity for Ajanta; Buy with a target price of Rs 1784 We expect at least $13m-15m in Ajanta's annual sales of g-Zegerid. The Zegerid-related patent (7399772) expired on 15th ...
 Equity Bulls2 months ago Ajanta Pharma Gets USFDA Nod For Generic Acid Reflux Drug  Businessworld India2 months ago Ajanta Pharma gets FDA nod for generic acid reflux drug  FirstWord Pharma2 months ago Dr Reddy’s launches Zegerid generic in US market  Business Line2 months ago
[x]  

Recent Analysts Ratings Changes for Valeant Pharmaceuticals International (VRX)

Several analysts have recently updated their ratings and price targets for Valeant Pharmaceuticals International (NYSE: VRX): 9/20/2016 Valeant Pharmaceuticals International is now covered by analysts at Deutsche Bank AG. They set a hold rating ...
 SleekMoney1 week ago Weekly Analysts Ratings Changes for Valeant Pharmaceuticals International (VRX)  SleekMoney2 weeks ago Valeant Pharmaceuticals International (VRX) Research Analysts Weekly Ratings Changes  American Banking News4 weeks ago Jefferies Group Reiterates Buy Rating for Valeant Pharmaceuticals International Inc. (VRX)  WKRB News1 month ago
[x]  
Minyanville

Nexium Lawsuit Filed By Bernstein Liebhard LLP On Behalf of Illinois Man Who Developed Chronic Kidney Disease Allegedly Related to Use of the Proton Pump Inhibitor

NEW YORK, Sept. 19, 2016 /PRNewswire/ --The nationwide law firm of Bernstein Liebhard LLP announces that they have filed a Nexium lawsuit ( http://www.nexiumlawsuit.com/ ) on behalf of an Illinois man who developed chronic kidney disease allegedly ...
 Yahoo! Finance1 week ago
[x]  

Teva's pricey Parkinson's drug unnerves some patients

Home » Health » / no comments The price ofone of the most commonly prescribed treatments for Parkinson's disease hassurged more than 200 percent over the past decade. That's making the drug,Teva Pharmaceutical'sAzilect,unaffordable for some ...
 HealthMediciNet.com2 weeks ago
Before It's News

Our Society Is Sick, Our Economy Exploitive and our Politics Corrupt

(Before It's News) Oftwominds.com s eclectic range of timely topics include finance, economy, stocks, housing, Asia, energy, long-term trends, social issues, urban planning, work/tradecraft, health/diet/fitness, sustainability, Les Paul guitars ...
 Before It's News1 month ago
[x]  
American Banking News - Earnings

Stock Analysts Updated EPS Estimates for August, 10th (ABX, ACAD, ACRX, AMAG, AMBC, ANTH, ARNA, COL, CYH, DF)

Stock Analysts updated eps estimates for Wednesday, August 10th: Barrick Gold Corp. (NYSE:ABX) had its price target boosted by Argus from $23.00 to $26.00. They currently have a buy rating on the stock. Acadia Pharmaceuticals (NASDAQ:ACAD) had ...
 American Banking News - Earnings1 month ago

CVS Formulary Drops Drugs With Egregious Price Hikes

CVS Health has announced that it is taking a stand against egregious drug price increases that unnecessarily add costs for clients and their members. Among the hyperinflationary drugs that will be removed from its 2017 formulary is Alcortin A ...
 P&T Community1 month ago CVS formulary nixes meds for 'egregious' price hikes  FiercePharma1 month ago

CVS Health Shortens Formulary List, Excluding 35 More Drugs

CVS Health intends to remove 35 drug productsused to treat patients with cancer, diabetes and hepatitis C from its standard 2017 formulary in order to address the financial impact of costly medications. According to CNBC , this announcement came ...
 PharmaceuticalProcessing1 month ago CVS Cuts Coverage of Dozens of Drugs in Exclusion Expansion  Bloomberg1 month ago CVS cuts coverage on dozens of drugs  MSN News US1 month ago

PERRIGO : Research Report on These Healthcare Sector Equities -- Valeant Pharma, Pernix Therapeutics, Perrigo, and Lipocine

/PRNewswire/ -- The number of individuals who require medical attention and treatment is constantly growing, which is why Healthcare stocks remain in high demand. Earnings growth potential within the healthcare sector is much higher compared with ...
 4 Traders1 month ago Research Report on These Healthcare Sector Equities Valeant Pharma, Pernix Therapeutics, Perrigo, and Lipocine  Pharmacy Choice1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Zegerid
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less